
Narval is pioneering a new generation of antibodies using Synthetic Antibody Mimetic Proteins™ (AMP) delivered through mucosal or skin tissues to locally treat diseases in the eyes, lungs, and skin. We design flexible, easier to use, and affordable antibody-like proteins without systemic side effect risks, creating new applications for biotherapeutics.

Narval is pioneering a new generation of antibodies using Synthetic Antibody Mimetic Proteins™ (AMP) delivered through mucosal or skin tissues to locally treat diseases in the eyes, lungs, and skin. We design flexible, easier to use, and affordable antibody-like proteins without systemic side effect risks, creating new applications for biotherapeutics.